Literature DB >> 23257875

Cancer: Metabolism in 'the driver's seat.

Luisa Tasselli, Katrin F Chua.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23257875     DOI： 10.1038/492362a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  Chromatin regulation and genome maintenance by mammalian SIRT6.

Authors:  Ruth I Tennen; Katrin F Chua
Journal:  Trends Biochem Sci       Date:  2010-08-21       Impact factor: 13.807

2.  The sirtuin SIRT6 regulates lifespan in male mice.

Authors:  Yariv Kanfi; Shoshana Naiman; Gail Amir; Victoria Peshti; Guy Zinman; Liat Nahum; Ziv Bar-Joseph; Haim Y Cohen
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

Review 3.  The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.

Authors:  Arnold J Levine; Anna M Puzio-Kuter
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

4.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

5.  Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice.

Authors:  Cuiying Xiao; Rui-Hong Wang; Tyler J Lahusen; Ogyi Park; Adeline Bertola; Takashi Maruyama; Della Reynolds; Qiang Chen; Xiaoling Xu; Howard A Young; Wan-Jun Chen; Bin Gao; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

6.  Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.

Authors:  Lihua Min; Yuan Ji; Latifa Bakiri; Zhixin Qiu; Jin Cen; Xiaotao Chen; Lingli Chen; Harald Scheuch; Hai Zheng; Lunxiu Qin; Kurt Zatloukal; Lijian Hui; Erwin F Wagner
Journal:  Nat Cell Biol       Date:  2012-10-07       Impact factor: 28.824

7.  The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.

Authors:  Carlos Sebastián; Bernadette M M Zwaans; Dafne M Silberman; Melissa Gymrek; Alon Goren; Lei Zhong; Oren Ram; Jessica Truelove; Alexander R Guimaraes; Debra Toiber; Claudia Cosentino; Joel K Greenson; Alasdair I MacDonald; Liane McGlynn; Fraser Maxwell; Joanne Edwards; Sofia Giacosa; Ernesto Guccione; Ralph Weissleder; Bradley E Bernstein; Aviv Regev; Paul G Shiels; David B Lombard; Raul Mostoslavsky
Journal:  Cell       Date:  2012-12-07       Impact factor: 41.582

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582
  8 in total
  10 in total

1.  A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity.

Authors:  J Cai; Y Zuo; T Wang; Y Cao; R Cai; F-L Chen; J Cheng; J Mu
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

2.  USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation.

Authors:  Zhenghong Lin; Heeyoung Yang; Can Tan; Jinping Li; Zhaojian Liu; Qiu Quan; Sinyi Kong; Junsheng Ye; Beixue Gao; Deyu Fang
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

Review 3.  Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.

Authors:  Fang Wei; Dan Wang; Junyuan Wei; Niwen Tang; Le Tang; Fang Xiong; Can Guo; Ming Zhou; Xiaoling Li; Guiyuan Li; Wei Xiong; Shanshan Zhang; Zhaoyang Zeng
Journal:  Cell Mol Life Sci       Date:  2020-07-11       Impact factor: 9.261

Review 4.  miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer.

Authors:  Daojiang Li; Lu Xia; Miao Chen; Changwei Lin; Hao Wu; Yi Zhang; Songqing Pan; Xiaorong Li
Journal:  Oncotarget       Date:  2017-07-25

5.  EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.

Authors:  Qilin Xu; Qunzhou Zhang; Yasutaka Ishida; Souren Hajjar; Xudong Tang; Haoran Shi; Chi V Dang; Anh D Le
Journal:  Oncotarget       Date:  2017-02-07

6.  Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis.

Authors:  Zhanjun Ma; Xue Cui; Li Lu; Guohu Chen; Yang Yang; Yan Hu; Yubao Lu; Zhangqi Cao; Yan Wang; Xuexi Wang
Journal:  Stem Cell Res Ther       Date:  2019-02-15       Impact factor: 6.832

7.  Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells.

Authors:  Asmaa Reda; Alaa Refaat; Ahmed A Abd-Rabou; Ali Mokhtar Mahmoud; Mohamed Adel; Salwa Sabet; Sameh Saad Ali
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

8.  Generalized portrait of cancer metabolic pathways inferred from a list of genes overexpressed in cancer.

Authors:  Eugenia Poliakov; David Managadze; Igor B Rogozin
Journal:  Genet Res Int       Date:  2014-08-27

9.  Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer.

Authors:  Se-Lim Kim; Soo Teik Lee; In Suk Min; Young Ran Park; Ju Hyung Lee; Dae-Ghon Kim; Sang-Wook Kim
Journal:  Cancer Sci       Date:  2017-09-22       Impact factor: 6.716

10.  STARD4 promotes breast cancer cell malignancy.

Authors:  Min Zhang; Zhen Xiang; Feng Wang; Rong Shan; Ling Li; Juan Chen; Bao-An Liu; Juan Huang; Lun-Quan Sun; Wei-Bing Zhou
Journal:  Oncol Rep       Date:  2020-10-12       Impact factor: 3.906
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.